Market Place
Sourcing Support
Scilex Pharma Announces FDA Meeting for SP-103 Path Forward
30 Oct 2024 //
GLOBENEWSWIRE
Scilex Announces Continuing Support From Endeavor
18 Sep 2024 //
GLOBENEWSWIRE
Scilex Holding Receives NABP Drug Distributor Accreditation
12 Sep 2024 //
GLOBENEWSWIRE
Scilex Announces Presentation At Rheumatology Conference
05 Sep 2024 //
GLOBENEWSWIRE
Scilex To Present On ZTlido At PAINWeek Conference In Las Vegas
30 Aug 2024 //
GLOBENEWSWIRE
Scilex Appoints Annu Navani To Board Of Directors
23 Jul 2024 //
GLOBENEWSWIRE
Scilex Partners With ACEA To Expand ZTlido In Far East
17 Jul 2024 //
GLOBENEWSWIRE
Aurobindo Pharma`s Generic Lidocaine Receives Approval in US
18 Jun 2024 //
FDA
Enforcement Report - Week of June 5, 2024
05 Jun 2024 //
FDA
Teikoku Announces Lidoderm® Approval In China
30 May 2024 //
PR NEWSWIRE
Enforcement Report - Week of February 14, 2024
14 Feb 2024 //
FDA
Scilex announces that ZTlido will be added as a preferred agent to PDL
06 Dec 2023 //
GLOBENEWSWIRE
Scilex announces the addition of ZTlido as a preferred agent to the Medicaid PDL
04 Dec 2023 //
GLOBENEWSWIRE
Scilex Holding Company Announces Issuance of New Patent in the U.S. for ZTlido
15 Nov 2023 //
GLOBENEWSWIRE
Scilex Announces New Data From Deeper Skin Penetration Studies to Support SP-103
02 Nov 2023 //
GLOBENEWSWIRE
Enforcement Report - Week of October 25, 2023
25 Oct 2023 //
FDA
Enforcement Report - Week of October 11, 2023
11 Oct 2023 //
FDA
Scilex Announces the Completion of SP-103 5.4%, Formulation of ZTlido, PII trial
14 Sep 2023 //
GLOBENEWSWIRE
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido
12 Sep 2023 //
GLOBENEWSWIRE
Pfizer says supply of some drugs may be disrupted after NC tornado
25 Jul 2023 //
FINANCE YAHOO
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Enforcement Report - Week of May 10, 2023
10 May 2023 //
FDA
Scilex Holding Company Announces Complete Enrollment of a pH 2 Study SP-103
04 May 2023 //
GLOBENEWSWIRE
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Scilex Announces Expanding Coverage With One Of The Largest PBMs For ZTlido
16 Aug 2022 //
GLOBENEWSWIRE
Scilex sues Apotex to block generic copy of key pain patch
28 Jun 2022 //
FIERCEPHARMA
Enforcement Report - Week Of June 01, 2022
01 Jun 2022 //
FDA
FDA confirms Paragraph IV Patent Litigation for Lidocaine.
05 May 2022 //
FDA
Aleor receives US FDA final approval for Lidocaine and Prilocaine cream
12 Apr 2022 //
EXPRESS PHARMA
Aleor Dermaceuticals Generic Lidocaine:Prilocaine Receives Approval in US
08 Apr 2022 //
FDA
Enforcement Report - Week of March 30, 2022
30 Mar 2022 //
FDA
Enforcement Report - Week of February 2, 2022
02 Feb 2022 //
FDA
Enforcement Report - Week of November 17, 2021
17 Nov 2021 //
FDA
A.Menarini soon to launch HA based dermal filler available with Lidocaine
21 Oct 2021 //
PHARMABIZ
Enforcement Report - Week of September 8, 2021
08 Sep 2021 //
FDA
Scilex Holding Announces Ztlido Managed Care Coverage for additional 33M Lives
19 Aug 2021 //
GLOBENEWSWIRE
Enforcement Report - Week of April 21, 2021
22 Apr 2021 //
FDA
Enforcement Report - Week of February 17, 2021
17 Feb 2021 //
FDA
Rhodes Pharms`s Generic Lidocaine: Prilocaine Receives Approval In US
21 Sep 2020 //
FDA
Amneal Pharmaceuticals Generic Lidocaine Receives Approval in US
25 Aug 2020 //
FDA
Enforcement Report - Week of August 19, 2020
19 Aug 2020 //
FDA
Enforcement Report - Week of June 3, 2020
03 Jun 2020 //
FDA
HHS, Industry Partners Expand U.S.-Based Pharma Manufacturing for COVID-19
20 May 2020 //
HHS
There Is a Lack of Evidence, Transparency About Ingredients to Support Use
13 May 2020 //
NATIONNALACADEMIES
Vapogenix Reports positive Phase II Result of Topical Non-Opioid Pain Medication
29 Oct 2019 //
BUSINESSWIRE
Sungen Pharma`s generic Lidocaine Receives Approval in US
19 Oct 2019 //
FDA
Premier’s ProvideGx™ Program Partners with Amphastar
08 Oct 2019 //
BIOSPACE
Enforcement Report - Week of September 25, 2019
26 Sep 2019 //
FDA
Xospata leads latest CHMP recommendations
21 Sep 2019 //
PHARMATIMES
EMA`s CHMP Recommends Three New Medicines
20 Sep 2019 //
RAPS
Enforcement Report - Week of August 14, 2019
14 Aug 2019 //
FDA
SnugZ USA, Inc. Receives FDA Warning Letter
09 Jul 2019 //
FDA
SnugZ USA, Inc Receives FDA Warning Letter
03 Jul 2019 //
FDA
Aratana Therapeutics Granted FDA Approval of NOCITA®
13 Jun 2019 //
PR NEWSWIRE
